1.Updates on biologic function of tumor suppressor gene inhibitor of growth family and related studies.
Chinese Journal of Pathology 2009;38(12):859-861
Animals
;
Apoptosis
;
Cell Cycle
;
Cell Cycle Proteins
;
genetics
;
metabolism
;
physiology
;
DNA Repair
;
Homeodomain Proteins
;
genetics
;
metabolism
;
physiology
;
Humans
;
Inhibitor of Growth Protein 1
;
Intracellular Signaling Peptides and Proteins
;
genetics
;
metabolism
;
physiology
;
Neoplasm Metastasis
;
Neoplasms
;
metabolism
;
pathology
;
Neovascularization, Pathologic
;
pathology
;
Nuclear Proteins
;
genetics
;
metabolism
;
physiology
;
Prognosis
;
Receptors, Cytoplasmic and Nuclear
;
genetics
;
metabolism
;
physiology
;
Signal Transduction
;
Transcription Factors
;
genetics
;
metabolism
;
physiology
;
Tumor Suppressor Protein p53
;
metabolism
;
Tumor Suppressor Proteins
;
chemistry
;
genetics
;
metabolism
;
physiology
4.Study Progress of Haparanase in Kidney Diseases
Journal of Applied Clinical Pediatrics 1992;0(05):-
Heparanase(HPA) is an endo-beta-D-glucuronidase that degrades heparan sulfate proteoglycans side chains.Recently data suggested a role of HPA in several proteinuric diseases and an increased glomerular basement membrane.The research advanced of the molecular properties,the role in proteinuric diseases and the specific inhibitor of the human HPA were described.
6.Myogenic sarcoma of pulmonary vein: report of a case.
Tao ZHU ; Zhi-nong JIANG ; Mei JIN
Chinese Journal of Pathology 2011;40(5):346-347
Adult
;
Desmin
;
metabolism
;
Diagnosis, Differential
;
Female
;
Heart Neoplasms
;
pathology
;
Humans
;
Myxoma
;
pathology
;
Ovarian Neoplasms
;
secondary
;
surgery
;
Pulmonary Veins
;
Sarcoma
;
diagnostic imaging
;
metabolism
;
pathology
;
secondary
;
surgery
;
Tomography, X-Ray Computed
;
Vascular Neoplasms
;
diagnostic imaging
;
metabolism
;
pathology
;
surgery
;
Vimentin
;
metabolism
8.Bilateral moderate hearing loss caused by mumps.
Chinese Journal of Pediatrics 2003;41(7):545-545
Child
;
Female
;
Hearing Loss, Bilateral
;
etiology
;
Humans
;
Mumps
;
complications
9.Percutaneous central venous catheter drainage for interventional treatment of complications in abdominal surgical diseases
Xin CHEN ; Zhidong XUAN ; Zhi ZHU
Chinese Journal of Primary Medicine and Pharmacy 2012;19(11):1652-1653
Objective To discuss the effica of central venous catheter drainage in interventional treatment of abdominal surgical complications.Methods The clinical data of 72 cases of abdominal surgical diseases were retrospectively analyzed,the complications included 23 cases of ascites,19 cases of bile leakage,8 cases of pancreatic fistula,7 cases of pancreatic necrosis and 15 cases of abdominal abscess,they all underwent percutaneous central venous catheter drainage under the guidance of ultrasound or CT.Results Central venous catheter was placed in 72 cases successfully in one time,the cathetem were kept for 2 to 37 days,5 discharged cases with catheter underwent regular reexamination in the clinic.3 cases of ascites were replaced for catheter shedding; 17 cases for occlusion recieved catheter irrigation and guidewire dredging;2 cases of pancreatic necrosis and 1 case of peripancreatic abscess were cured by repeated puncture and replacement of large-bore catheter.2 cases of pancreatic necrosis,1 case of pancreatic fistula and 1 case of appendicitis underwent laparotomy finally; 1 case of postcholecystectomy bile leakage underwent endoscopic stent therapy; 1 cases of severe pancreatitis complicated with ARDS was treated in ICU.Conclusion Central venous catheter drainage guided by ultrasound or CT for treatment of abdominal surgical complications was not only safe but also effective,and is worthy of popularization and application.
10.Advances in human placenta-derived stem cells for liver regeneration
Jian WANG ; Zhengyan ZHU ; Zhi DU
Chinese Journal of Hepatobiliary Surgery 2013;(3):236-240
Human placenta-derived stem cells (hPD-SCs) are a mixed group of stem cells.Stem cell medicine has applications for organ damage or failure through regenerative,anti-apoptotic,anti-inflammatory and anti-tumor properties in addition to cell function recovery.Presently,human placenta mesenchymal stem cells (hPMSCs) have similar characteristics to the differentiation of hepatocyte-like cells by promoting hepatocyte regeneration,anti-hepatocyte apoptosis and anti-liver fibrosis,in vitro or in animal models.To further our investigation,a summary of the origin,sorting and biological properties of hPDSCs along with a narration of hPDSCs for liver disease therapy was written.This leads to a discussion for new ideas to further explore cell treatment for liver disease.